If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
First generic launch in antibiotic class and first to market LAKE FOREST, Ill., June 22 (HSMN NewsFeed) — Hospira, Inc. (NYSE:HSP ), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administra…
Biopharmaceuticals, Generics, FDA
Hospira, meropenem, AstraZeneca, Merrem
Posts from ‘June, 2010’
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
InnerSpace Announces U.S. Market Launch of Hummingbird Neuromonitoring Line
TUSTIN, Calif.–(HSMN NewsFeed)–InnerSpace, Inc. today announced the U.S. market launch of the Hummingbird Synergy, Hummingbird Ventricular, and Hummingbird Parenchyma for the management of traumatic brain injury. Hummingbird Synergy is designed to pro…
Devices, Monitoring, Neurosurgery
InnerSpace, Hummingbird, Intracranial Pressure
Data Show OrbusNeich’s Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
Results Presented at the World Congress of Cardiology Scientific Sessions 2010 in Beijing BEIJING, June 21 (HSMN NewsFeed) — OrbusNeich today announced that six-month clinical follow-up data show the safety and efficacy of the combination of pre-dila…
Devices, Interventional Cardiology
OrbusNeich, Genous Bio-engineered R stent
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg(R)
Required Post-Marketing Study did not Confirm Clinical Benefit of Mylotarg Pfizer to Ensure Continued Access for Current Mylotarg Patients NEW YORK, June 21 (HSMN NewsFeed) — Pfizer Inc. (NYSE:PFE ) announced today that based on talks with t…
Biopharmaceuticals, Oncology
Pfizer, Mylotarg, gemtuzumab ozogamicin, acute myeloid leukemia
New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan
Data from comparator trial presented at the European Society of Hypertension (ESH) Annual Scientific Meeting DEERFIELD, Ill., June 21 (HSMN NewsFeed) — Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) today announced results from …
Biopharmaceuticals, Cardiology
Takeda Clinical, azilsartan medoxomil, Hypertension
Ardian(R) Demonstrates 2-Year Durability of Blood Pressure Reduction in Hypertension Patients Treated with Symplicity(R) Catheter System(TM)
PALO ALTO, Calif., June 21 (HSMN NewsFeed) — Long-term data presented today from Ardian’s SYMPLICITY HTN-1 study demonstrate that the significant reductions in blood pressure achieved using Renal Denervation (RDN) treatment are sustained through 24 mont…
Devices, Cardiology
Ardian, Symplicity Catheter, hypertension
Neupro(R) (rotigotine) significantly improved wellbeing and every day activities impaired due to limb pain associated with Restless Legs Syndrome
Data presented at leading international congress Additional five-year open-label data provided evidence for long-term safety and efficacy of Neupro® (rotigotine) in Restless Legs Syndrome (RLS) BRUSSELS, BELGIUM - (HSMN NewsFeed) - The first data t…
Biopharmaceuticals
UCB, Neupro, rotigotine, Restless Legs Syndrome
Medicis Announces Organizational Changes
SCOTTSDALE, Ariz., June 18, 2010 –(HSMN NewsFeed) — Medicis (NYSE:MRX ) today announced several organizational changes and promotions which are designed to job the Company for future growth and optimize allocation of human resources within the Compa…
Biopharmaceuticals, Personnel
Medicis Clinical
Study: Medtronic Anatomically-Designed Catheters Reduce Clinical laboratory Time Required for Pulmonary Vein Isolation by 35 %
Data from FAST-PVI Study Presented at Cardiostim 2010 MINNEAPOLIS, & WORTHY, France–(HSMN NewsFeed)–Data from the FAST-PVI study, supported by Medtronic, Inc. (NYSE: MDT ), shows laboratory time using anatomically-designed ablation catheters are more than one-…
Devices, Cardiology
Medtronic, Arctic Front, Cardiac CryoAblation, cardiac ablation
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Medical Affairs and Quality Assurance
Industry Veteran to Support Rapidly Advancing Pipeline WARREN, N.J., June 17 (HSMN NewsFeed) — MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the appointment of Mary Ellen Norvitch, Ph.D. to the newly created po…
Biopharmaceuticals, Drug Delivery, Personnel
MonoSol Rx
